About Isaac Barchas
Form D filings for MorphImmune from 2022 to 2023 list Isaac Barchas as director.
Isaac Barchas first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Isaac Barchas in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Isaac Barchas works with at each company, as listed on that company's latest Form D.
MorphImmune Inc. · Form D, May 17, 2023
SD
Sunil Singhal, M.D.
Director
PD
Philip Low, Ph.D.
Director
CD
Clay Siegall, Ph.D.
President and Chief Executive Officer, director
RM
Ronald Martell
Director
FD